Juan Rodriguez Acosta, MD
Cardiology · Mayaguez, PRNPI 1114992443
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $11,761 of the $15,249 with a category attached, or 77.1%. 18 manufacturers reported payments, led by Medtronic at 57.8% of the total.
Across 385 payments — averaging $39.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$9K
- Boston Scientific$1K
- AstraZeneca$1K
- Abbott$963
- Boehringer Ingelheim$593
- Johnson & Johnson$567
- plus $2K from 12 others
What the payments were for
- Consulting fees$2,10014%
- Speaking & faculty fees$7005%
- Travel & lodging$4183%
- Food & beverage$11,76177%
- Education$1951%
- Gifts$750%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 147 | $8,812 |
| Boston Scientific | 64 | $1,371 |
| AstraZeneca | 47 | $1,187 |
| Abbott | 45 | $963 |
| Boehringer Ingelheim | 10 | $593 |
| Johnson & Johnson | 18 | $567 |
| E.r. Squibb & Sons, L.L.C. | 18 | $443 |
| Edwards Lifesciences | 2 | $254 |
| PBG Puerto Rico LLC | 12 | $246 |
| Bayer | 2 | $191 |
| Merck | 3 | $164 |
| Chiesi USA, Inc. | 4 | $136 |
| Novartis | 5 | $104 |
| Amgen | 2 | $92 |
| Bayer Puerto Rico Inc. | 2 | $50 |
| Terumo Medical Corporation | 2 | $40 |
| Sanofi-aventis U.S. LLC | 1 | $24 |
| Cordis US CORP. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ONYX FRONTIER$652
- CoreValve Evolut$385
- ENDURANT IIS$363
- COBALT DR MRI SURESCAN$308
- SYMPLICITY G3$269
- JARDIANCE$234
- LOKELMA$202
- INSPIRIS RESILIA aortic valve$164
- Kerendia$125
- AURORA EV-ICD MRI SURESCAN$117
- AVEIR$103
How this compares
Too few cardiology providers in Puerto Ricoto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BrilintaTicagrelor | 163 | $74,538 |
| EliquisApixaban | 45 | $28,329 |
| FarxigaDapagliflozin Propanediol | 46 | $28,118 |
| EntrestoSacubitril/Valsartan | 26 | $21,442 |
| XareltoRivaroxaban | 12 | $6,903 |
| ClopidogrelClopidogrel Bisulfate | 188 | $1,393 |
| Candesartan Cilexetil | 24 | $1,222 |
| Nitroglycerin PatchNitroglycerin | 24 | $942 |
| Losartan Potassium | 110 | $890 |
| Metoprolol Succinate | 71 | $805 |
| Atorvastatin Calcium | 75 | $591 |
| Nitroglycerin | 35 | $448 |
| Isosorbide Dinitrate | 13 | $407 |
| Carvedilol | 54 | $370 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 37 | $360 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaBrilinta, Farxiga | $1,187 | $102,656209 claims |
| NovartisEntresto | $104 | $21,44226 claims |
| Johnson & JohnsonXarelto | $567 | $6,90312 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few cardiology providers in Puerto Ricoon file to place this against a meaningful peer group, so we don't.
Other cardiology in Mayaguez
- Hiram Cardona-MartinezMayaguez$3K
- Noemi Benitez CharnecoMayaguez$746
- Antonio Renta MunozHato Rey$36K
- Norma Devarie DiazSan Juan$8K
- Rafael Ufret-PerezCaguas$7K
- Jose Martinez ToroSan Juan$5K
- Felix Rios GonzalezTrujillo Alto$4K
- Alexis Rivera-DavilaFajardo$4K
- Manuel ArecesSanjuan$4K
- Ralph Conaway LanuzaHato Rey$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.